ImmunoTarget Therapeutics Inc is a biotechnology company addressing development of personalized immunotherapies for the treatment of cancer. Structured around taking personalized medicine to a convenient level, the effort is to enable treatmernt of patents having cancer, infectious diseases and autoimmune disorders by facilitating use of proprietary cell processing techniques to train each patient's own immune system to fight their cancer cells,
